- Corporate Officers - B
- Bonstein Sara
Insider Trading History of Bonstein Sara
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bonstein Sara since 2017.
This trader's CIK number is 1604019.
At the time of last reporting, Bonstein Sara was the Chief Financial Officer of Insmed Inc. (stock ticker symbol INSM).
Also see all insider trading activities at Insmed Inc.
Note that in the past
Bonstein Sara also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Oncosec Medical Inc (ONCS) by Bonstein Sara
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | ONCS | 0 | $0 | 1,351 | $2,810 | 0 | $0 |
| 2019 | ONCS | 0 | $0 | 1,111 | $2,233 | 0 | $0 |
Yearly summary of insider trading at Insmed Inc (INSM) by Bonstein Sara
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | INSM | 0 | $0 | 313,232 | $28,936,664 | 191,555 | $4,372,850 |
| 2024 | INSM | 0 | $0 | 256,873 | $12,476,577 | 241,288 | $6,336,704 |
| 2023 | INSM | 0 | $0 | 19,876 | $520,127 | 0 | $0 |
| 2022 | INSM | 0 | $0 | 2,587 | $55,500 | 0 | $0 |
Yearly summary of insider trading at Ayala Pharmaceuticals, Inc. (ADXS) by Bonstein Sara
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | ADXS | 0 | $0 | 5,224 | $16,612 | 0 | $0 |
| 2017 | ADXS | 0 | $0 | 22,116 | $94,047 | 0 | $0 |
Insider trading activities at 3 companies by Bonstein Sara:
1. Oncosec Medical Inc (ONCS)
2. Insmed Inc (INSM)
3. Ayala Pharmaceuticals, Inc. (ADXS)
Table 1. Insider trading of Oncosec Medical Inc (ONCS) by Bonstein Sara
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-01-16 | ONCS | Sale | 1,351 | 2.08 | 2,810 |
| 2019-10-16 | ONCS | Sale | 1,111 | 2.01 | 2,233 |
Table 2. Insider trading of Insmed Inc (INSM) by Bonstein Sara
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-07-21 | INSM | Option Ex | 47,888 | 29.62 | 1,418,682 |
| 2025-07-21 | INSM | Sale | 58,400 | 102.70 | 5,997,972 |
| 2025-07-07 | INSM | Option Ex | 47,888 | 24.33 | 1,165,258 |
| 2025-07-07 | INSM | Sale | 57,764 | 95.92 | 5,541,011 |
| 2025-06-23 | INSM | Option Ex | 47,889 | 19.34 | 926,412 |
| 2025-06-23 | INSM | Sale | 57,765 | 101.93 | 5,887,986 |
| 2025-06-10 | INSM | Option Ex | 47,890 | 18.01 | 862,498 |
| 2025-06-10 | INSM | Sale | 57,766 | 89.47 | 5,168,497 |
| 2025-05-14 | INSM | Sale | 1,634 | 65.61 | 107,206 |
| 2025-05-13 | INSM | Sale | 8,870 | 67.81 | 601,474 |
| 2025-02-18 | INSM | Sale | 18,322 | 80.64 | 1,477,486 |
| 2025-02-11 | INSM | Sale | 13,302 | 80.00 | 1,064,160 |
| 2025-02-12 | INSM | Sale | 5,019 | 80.00 | 401,520 |
| 2025-02-06 | INSM | Sale | 28,390 | 80.90 | 2,296,751 |
| 2025-01-07 | INSM | Sale | 3,470 | 65.70 | 227,979 |
| 2025-01-08 | INSM | Sale | 1,464 | 66.05 | 96,697 |
| 2025-01-10 | INSM | Sale | 1,066 | 63.72 | 67,925 |
| 2024-05-28 | INSM | Option Ex | 20,724 | 26.26 | 544,253 |
| 2024-05-29 | INSM | Option Ex | 220,564 | 26.26 | 5,792,451 |
| 2024-05-28 | INSM | Sale | 20,724 | 50.01 | 1,036,407 |
| 2024-05-29 | INSM | Sale | 220,564 | 50.00 | 11,028,200 |
| 2024-05-14 | INSM | Sale | 11,088 | 25.32 | 280,748 |
| 2024-01-09 | INSM | Sale | 4,497 | 29.18 | 131,222 |
| 2023-12-22 | INSM | Sale | 13,199 | 30.00 | 395,970 |
| 2023-05-15 | INSM | Sale | 2,210 | 19.30 | 42,653 |
| 2023-05-16 | INSM | Sale | 1,610 | 18.47 | 29,736 |
| 2023-01-10 | INSM | Sale | 2,857 | 18.12 | 51,768 |
| 2022-05-16 | INSM | Sale | 1,433 | 18.51 | 26,524 |
| 2022-01-11 | INSM | Sale | 1,154 | 25.11 | 28,976 |
Table 3. Insider trading of Ayala Pharmaceuticals, Inc. (ADXS) by Bonstein Sara
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-01-03 | ADXS | Sale | 5,224 | 3.18 | 16,612 |
| 2017-11-06 | ADXS | Sale | 3,862 | 3.30 | 12,744 |
| 2017-11-02 | ADXS | Sale | 12,734 | 3.19 | 40,621 |
| 2016-12-30 | ADXS | Sale | 5,520 | 7.37 | 40,682 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Bonstein Sara
(Chief Financial Officer of Insmed Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.